Breast Cancer, Version 3.2020

被引：628

作者：

Gradishar, William J. ^{[1
]}

Anderson, Benjamin O. ^{[2
]}

Abraham, Jame ^{[3
,4
]}

Aft, Rebecca ^{[5
,6
]}

Agnese, Doreen ^{[7
,8
]}

Allison, Kimberly H. ^{[9
]}

Blair, Sarah L. ^{[10
]}

Burstein, Harold J. ^{[11
]}

Dang, Chau ^{[12
]}

Elias, Anthony D. ^{[13
]}

Giordano, Sharon H. ^{[14
]}

Goetz, Matthew P. ^{[15
]}

Goldstein, Lori J. ^{[16
]}

Isakoff, Steven J. ^{[17
]}

Krishnamurthy, Jairam ^{[18
]}

Lyons, Janice ^{[3
,4
]}

Marcom, P. Kelly ^{[19
]}

Matro, Jennifer ^{[20
]}

Mayer, Ingrid A. ^{[21
]}

Moran, Meena S. ^{[22
]}

Mortimer, Joanne ^{[23
]}

O'Regan, Ruth M. ^{[24
]}

Patel, Sameer A. ^{[16
]}

Pierce, Lori J. ^{[25
]}

Rugo, Hope S. ^{[26
]}

Sitapati, Amy ^{[10
]}

Smith, Karen Lisa ^{[27
]}

Smith, Mary Lou ^{[28
]}

Soliman, Hatem ^{[29
]}

Stringer-Reasor, Erica M. ^{[30
]}

Telli, Melinda L. ^{[9
]}

Ward, John H. ^{[31
]}

Young, Jessica S. ^{[32
]}

Burns, Jennifer L. ^{[33
]}

Kumar, Rashmi ^{[33
]}

机构：

[1] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA

[2] Seattle Canc Care Alliance, Fred Hutchinson Canc Res Ctr, Seattle, WA USA

[3] Univ Hosp Seidman Canc Ctr, Case Comprehens Canc Ctr, Cleveland, OH USA

[4] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA

[5] Barnes Jewish Hosp, Siteman Canc Ctr, St Louis, MO 63110 USA

[6] Washington Univ, Sch Med, St Louis, MO USA

[7] Ohio State Univ, Comprehens Canc Ctr, James Canc Hosp, Columbus, OH 43210 USA

[8] Solove Res Inst, Columbus, OH USA

[9] Stanford Canc Inst, Stanford, CA USA

[10] UC San Diego Moores Canc Ctr, La Jolla, CA USA

[11] Dana Farber Brigham & Womens Canc Ctr, Boston, MA USA

[12] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[13] Univ Colorado, Canc Ctr, Boulder, CO 80309 USA

[14] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[15] Mayo Clin, Canc Ctr, Rochester, MN USA

[16] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA

[17] Massachusetts Gen Hosp, Canc Ctr, Boston, MA 02114 USA

[18] Fred & Pamela Buffet Canc Ctr, Omaha, NE USA

[19] Duke Canc Inst, Durham, NC USA

[20] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA

[21] Vanderbilt Ingram Canc Ctr, Nashville, TN USA

[22] Smilow Canc Hosp, Yale Canc Ctr, New Haven, CT USA

[23] City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA

[24] Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53706 USA

[25] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI 48109 USA

[26] UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA

[27] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA

[28] Res Advocacy Network, Plano, TX USA

[29] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[30] UAB, ONeal Comprehens Canc Ctr, Barcelona, Spain

[31] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA

[32] Roswell Park Comprehens Canc Ctr, Buffalo, NY USA

[33] Natl Comprehens Canc Network, Plymouth Meeting, PA USA

来源：

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2020年 / 18卷 / 04期

关键词：

PHASE-III TRIAL; FULVESTRANT; 500; MG; FIRST-LINE THERAPY; ANASTROZOLE; LAPATINIB PLUS CAPECITABINE; AROMATASE INHIBITOR THERAPY; PROGRESSION-FREE SURVIVAL; ALBUMIN-BOUND PACLITAXEL; SCALP COOLING DEVICE; EPOTHILONE-B ANALOG;

D O I：

10.6004/jnccn.2020.0016

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Several new systemic therapy options have become available for patients with metastatic breast cancer, which have led to improvements in survival. In addition to patient and clinical factors, the treatment selection primarily depends on the tumor biology (hormone-receptor status and HER2-status). The NCCN Guidelines specific to the workup and treatment of patients with recurrent/stage IV breast cancer are discussed in this article.

引用

页码：452 / 478

页数：27

共 181 条

[91] Management of Chemotherapy-Induced Alopecia With Scalp Cooling [J].

Kruse, Megan ;

Abraham, Jame .

JOURNAL OF ONCOLOGY PRACTICE, 2018, 14 (03) :149-+

[92] Performance of Prediction Models for BRCA Mutation Carriage in Three Racial/Ethnic Groups: Findings from the Northern California Breast Cancer Family Registry [J].

Kurian, Allison W. ;

Gong, Gail D. ;

John, Esther M. ;

Miron, Alexander ;

Felberg, Anna ;

Phipps, Amanda I. ;

West, Dee W. ;

Whittemore, Alice S. .

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (04) :1084-1091

[93] Phase III trial of epirubicin plus paclitaxel compared with epirubicin plus cyclophosphamide as first-line chemotherapy for metastatic breast cancer: United Kingdom National Cancer Research Institute Trial AB01 [J].

Langley, RE ;

Carmichael, J ;

Jones, AL ;

Cameron, DA ;

Qian, WD ;

Uscinska, B ;

Howell, A ;

Parmar, M .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (33) :8322-8330

[94]

Lipton A, 2000, CANCER, V88, P1082, DOI 10.1002/(SICI)1097-0142(20000301)88:5<1082::AID-CNCR20>3.0.CO

[95]

2-Z

[96] Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation [J].

Litton, Jennifer K. ;

Rugo, Hope S. ;

Ettl, Johannes ;

Hurvitz, Sara A. ;

Goncalves, Anthony ;

Lee, Kyung-Hun ;

Fehrenbacher, Louis ;

Yerushalmi, Rinat ;

Mina, Lida A. ;

Martin, Miguel ;

Roche, Henri ;

Im, Young-Hyuck ;

Quek, Ruben G. W. ;

Markova, Denka ;

Tudor, Iulia C. ;

Hannah, Alison L. ;

Eiermann, Wolfgang ;

Blum, Joanne L. .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (08) :753-763

[97] Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years [J].

Malone, Kathleen E. ;

Daling, Janet R. ;

Doody, David R. ;

Hsu, Li ;

Bernstein, Leslie ;

Coates, Ralph J. ;

Marchbanks, Polly A. ;

Simon, Michael S. ;

McDonald, Jill A. ;

Norman, Sandra A. ;

Strom, Brian L. ;

Burkman, Ronald T. ;

Ursin, Giske ;

Deapen, Dennis ;

Weiss, Linda K. ;

Folger, Suzanne ;

Madeoy, Jennifer J. ;

Friedrichsen, Danielle M. ;

Suter, Nicola M. ;

Humphrey, Mariela C. ;

Spirtas, Robert ;

Ostrander, Elaine A. .

CANCER RESEARCH, 2006, 66 (16) :8297-8308

[98] Gemcitabine plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes:: final results of the phase III Spanish Breast Cancer Research Group (GEICAM) trial [J].

Martin, Miguel ;

Ruiz, Amparo ;

Munoz, Monserrat ;

Balil, Ana ;

Garcia-Mata, Jesus ;

Calvo, Lourdes ;

Carrasco, Eva ;

Mahillo, Esther ;

Casado, Antonio ;

Angel Garcia-Saenz, Jose ;

Jose Escudero, M. ;

Guillem, Vicente ;

Jara, Carlos ;

Ribelles, Nuria ;

Salas, Fernando ;

Soto, Celia ;

Morales-Vasquez, Flavia ;

Rodriguez, Cesar A. ;

Adrover, Encarna ;

Ramon Mel, Jose .

LANCET ONCOLOGY, 2007, 8 (03) :219-225

[99] Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: Meta-analysis [J].

Mauri, Davide ;

Pavlidis, Nicholas ;

Polyzos, Nikolaos P. ;

Ioannidis, John P. A. .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (18) :1285-1291

[100] Overall survival benefit for weekly vs. three-weekly taxanes regimens in advanced breast cancer: A meta-analysis [J].

Mauri, Davide ;

Kamposioras, Konstantinos ;

Tsali, Lamprini ;

Bristianou, Magdalini ;

Valachis, Antonis ;

Karathanasi, Ioanna ;

Georgiou, Christos ;

Polyzos, Nikolaos P. .

CANCER TREATMENT REVIEWS, 2010, 36 (01) :69-74

← 5 6 7 8 9 10 11 12 13 14 →